ALPS Advisors’s Minerva Neurosciences NERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-9,725
| Closed | -$603K | – | 845 |
|
|
2019
Q3 | $603K | Sell |
9,725
-485
| -5% | -$30.1K | ﹤0.01% | 466 |
|
|
2019
Q2 | $460K | Sell |
10,210
-1,526
| -13% | -$68.8K | ﹤0.01% | 554 |
|
|
2019
Q1 | $738K | Buy |
11,736
+508
| +5% | +$31.9K | 0.01% | 398 |
|
|
2018
Q4 | $605K | Buy |
11,228
+2,651
| +31% | +$143K | ﹤0.01% | 435 |
|
|
2018
Q3 | $861K | Buy |
8,577
+1,547
| +22% | +$155K | 0.01% | 439 |
|
|
2018
Q2 | $464K | Buy |
7,030
+542
| +8% | +$35.8K | ﹤0.01% | 661 |
|
|
2018
Q1 | $324K | Buy |
6,488
+1,127
| +21% | +$56.3K | ﹤0.01% | 808 |
|
|
2017
Q4 | $259K | Buy |
5,361
+128
| +2% | +$6.18K | ﹤0.01% | 765 |
|
|
2017
Q3 | $318K | Buy |
5,233
+1,092
| +26% | +$66.4K | ﹤0.01% | 724 |
|
|
2017
Q2 | $293K | Buy |
4,141
+398
| +11% | +$28.2K | ﹤0.01% | 722 |
|
|
2017
Q1 | $243K | Sell |
3,743
-438
| -10% | -$28.4K | ﹤0.01% | 704 |
|
|
2016
Q4 | $393K | Buy |
+4,181
| New | +$393K | ﹤0.01% | 604 |
|